ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Randomized Trial of Dietary Intervention Therapy in Obese Hypertensives (DITOH)

This study has been completed.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00000515
  Purpose

To determine the effects on blood pressure of dietary intervention, restricting caloric intake to 600 calories per day for 16 weeks compared to a control diet of 1200 calories per day in obese hypertensives. Secondary aims included a study of psychological characteristics at baseline and during the weight loss and maintenance phases of the study.


Condition Intervention Phase
Cardiovascular Diseases
Heart Diseases
Hypertension
Obesity
Behavioral: diet, reducing
Phase III

MedlinePlus related topics:   Heart Diseases    High Blood Pressure    Obesity    Weight Control   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Parallel Assignment

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date:   July 1984

Detailed Description:

BACKGROUND:

Hypertension is a highly prevalent disorder contributing to a large proportion of cardiovascular morbidity and mortality in the United States. Although drug therapy of elevated blood pressure can reduce the risks of cardiovascular morbidity and mortality, such therapy constitutes significant expense for individuals over long periods of time as well as large national expenditures. In addition, the side effects of drug therapy may be significant. DITOH would provide much needed information concerning the effects of various means of weight reduction on blood pressure as possible definitive therapy for hypertension or as an approach which could be combined with reduced drug dosages.

DESIGN NARRATIVE:

Randomized. After three weeks on a control diet, subjects were randomized to the Protein Sparing Modified Fast Diet which provided 600 calories per day (1.5 grams per kilogram of ideal body weight of high quality protein plus 19 grams of fat) or to a 1200 calorie per day Balanced Deficit Diet. After 16 weeks in the weight-loss phase, subjects entered the maintenance program for 20 weeks. Both diets were supplemented with vitamins, minerals, and fluids. The Protein Sparing Modified Fast Diet was supplemented with 5 grams of salt given as bouillon to equal the salt intake of the Balanced Deficit Diet. Patients were followed for 24 months after the end of the weight loss phase. The primary endpoint was change in diastolic blood pressure. Individuals who continued to have diastolic pressures above 104 mm Hg following the initial 16 week treatment period were treated with antihypertensive drugs.

  Eligibility
Ages Eligible for Study:   25 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Men and women, ages 25 to 55. Subjects were obese, weighing between 130 and 210 percent of ideal body weight. Subjects had diastolic blood pressures between 90 and 105 mm Hg and were not on antihypertensive medications.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000515

Sponsors and Collaborators

Investigators
Investigator:     George Blackburn     Beth Israel Deaconess Medical Center    
  More Information


Study ID Numbers:   34
First Received:   October 27, 1999
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00000515
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Obesity
Heart Diseases
Vascular Diseases
Nutrition Disorders
Overweight
Overnutrition
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers